Clinical Trials

Title   A phase 1B/2 multi-center, double-blind (principal investigators and study subjects blinded, sponsor unblinded), placebo-controlled, randomized, single-ascending dose study to assess the safety, pharmacokinetics, and pharmacodynamics of DS-1040B in subje
Description   This is a Phase 1b/2, double-blind (principal investigator and study subjects blinded, Sponsor unblinded), placebo controlled, randomized, single-ascending dose, multi-center study to assess the safety, tolerability, PK, and pharmacodynamics (PD) of DS-1040b in subjects with AIS.
IRB Number   17-082
Treatment   Acute Ischemic Stroke
Status   Active
Principal Name   Steve Cordina, M.D.
Contact Name   Tatiana Torres Herman

Email Newsletters

Connect With Us